ARTICLE | Financial News
ContraVir completes follow-on
April 27, 2017 9:12 PM UTC
Infectious disease company ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) raised $12 million on April 25 through the sale of 12 million shares at $1 in a follow-on underwritten by Canaccord Genuity and ...
BCIQ Company Profiles